dopa decarboxylase inhibitors
Levodopa,       administered orally, usually combined with peripheral dopa decarboxylase       inhibitors, continues to be the most widely-used and most effective       pharmacological treatment for Parkinson's disease (Melamed, 1987).
 @OBJECT$ ,       administered orally, usually  @PREDICAT$  with peripheral  @SUBJECT$ , continues to be the most widely-used and most effective       pharmacological treatment for Parkinson's disease (Melamed, 1987).